Startpage Bosch.com Bosch Packaging
Packaging Technology
Corporate information
Information
Bosch Group
News Overview

In Small Doses

Despite the current economic crisis, the drug development pipeline is still quite robust. There are 9,605 drugs being developed in 2009 according to the Pharma R&D Annual Review published in May 2009. This is a plus of 2,400 compared to 2005 and almost twice as much as in 2000. Clinical trials are a critical component of the drug development process, determining which drugs will be taken to market and generate revenue to compensate for the costly R&D cycle. Due to smaller production volumes, lines used to produce drugs for clinical trial operations have always had distinct needs in terms of processing equipment. Additionally, a number of industry trends are changing the drug development landscape, and these changes are having important effects on clinical trial and pilot drug production.

…

Download PDF (1,5 MB)

For more information please contact:

Inga Strobel
Phone +49 7951 402-648
inga.strobel@bosch.com
back to the overview
  back to top